Jacobs Levy Equity Management
TWST icon

Jacobs Levy Equity Management’s Twist Bioscience TWST Stock Holding History

Jacobs Levy Equity Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-103,117
Closed -$3.27M – 1069
2025
Q4 		$3.27M Sell
103,117
-394,021
-79% -$12.3M 0.01% 494
2025
Q3 		$14M Buy
497,138
+134,929
+37% +$4.09M 0.06% 248
2025
Q2 		$13.3M Buy
362,209
+319,886
+756% +$11.1M 0.05% 263
2025
Q1 		$1.66M Buy
+42,323
New +$1.91M 0.01% 703

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jacobs Levy Equity Management's TWST Position: Q1 2026 in Review

Jacobs Levy Equity Management sold out of Twist Bioscience (TWST) in Q1 2026, closing a stake of 103,117 shares — an estimated $3.27M sold.

Jacobs Levy Equity Management first reported a position in TWST in Q1 2025 and held it in 4 quarters. The position peaked at $14M in Q3 2025. 281 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Jacobs Levy Equity Management reported no remaining Twist Bioscience position as of Q1 2026 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 103,117 Twist Bioscience shares in Q1 2026, an estimated $3.27M.
  • Jacobs Levy Equity Management first reported a position in Twist Bioscience in Q1 2025 and held it in 4 quarters.
  • Jacobs Levy Equity Management's Twist Bioscience position peaked at $14M in Q3 2025.
  • 281 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.